Table 4. Clinical response to NACT between the two age groups in patients with stage IB1-IB2 and squamous carcinoma.
IB1-IB2 | |||
---|---|---|---|
≤35 | >35 | Pa | |
Squamous cell carcinoma | |||
CR+PR | 68 (93.2%) | 220 (81.8%) | 0.018 |
SD+PD | 5 (6.8%) | 49 (18.2%) |
NACT, neoadjuvant chemotherapy; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.
a P value was calculated using the chi-square test.